Player FM 앱으로 오프라인으로 전환하세요!
1751: Dr. Ben Pope Details His Research On Diabetes, Insulin Resistance, And Finding A Cure
저장한 시리즈 ("피드 비활성화" status)
When? This feed was archived on July 11, 2018 01:02 (). Last successful fetch was on January 24, 2023 13:18 ()
Why? 피드 비활성화 status. 잠시 서버에 문제가 발생해 팟캐스트를 불러오지 못합니다.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 299149828 series 3898
On today’s episode of the LLVLC Show, Jimmy welcomes Dr. Ben Pope to talk about his latest research into finding a cure for diabetes.
“There are actually no drugs on the market that target the fat cells for weight loss.”
Dr. Ben Pope
In this new interview, Jimmy speaks with the Co-founder and Chief Scientific Officer of a startup company called Mellicell named Dr. Ben Pope about their stated goal to create a cure for diabetes. Dr. Pope was recommended to Jimmy by fellow researcher and former podcast interview guest Dr. Ben Bikman and the conversation took a deep dive looking closer at the role fat cells play in the diabetes epidemic, what role nutrition and biohacking lifestyle techniques are playing in the company’s plan, and a whole lot more. With both of his parents being diagnosed with Type 2 diabetes two decades ago, this topic is personal for Ben and is the impetus for creating an educational resource or possible drug that could provide the ever-elusive cure for diabetes.
Dr. Ben Pope is Co-founder and Chief Scientific Officer at MelliCell. Cross-trained in biology and engineering, Ben brings interdisciplinary expertise and management experience to lead our scientific and technology development efforts. Ben has been pursuing a cure for diabetes since his parents’ diagnosis over 20 years ago and is an inventor of MelliCell’s core technology.
832 에피소드
저장한 시리즈 ("피드 비활성화" status)
When? This feed was archived on July 11, 2018 01:02 (). Last successful fetch was on January 24, 2023 13:18 ()
Why? 피드 비활성화 status. 잠시 서버에 문제가 발생해 팟캐스트를 불러오지 못합니다.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 299149828 series 3898
On today’s episode of the LLVLC Show, Jimmy welcomes Dr. Ben Pope to talk about his latest research into finding a cure for diabetes.
“There are actually no drugs on the market that target the fat cells for weight loss.”
Dr. Ben Pope
In this new interview, Jimmy speaks with the Co-founder and Chief Scientific Officer of a startup company called Mellicell named Dr. Ben Pope about their stated goal to create a cure for diabetes. Dr. Pope was recommended to Jimmy by fellow researcher and former podcast interview guest Dr. Ben Bikman and the conversation took a deep dive looking closer at the role fat cells play in the diabetes epidemic, what role nutrition and biohacking lifestyle techniques are playing in the company’s plan, and a whole lot more. With both of his parents being diagnosed with Type 2 diabetes two decades ago, this topic is personal for Ben and is the impetus for creating an educational resource or possible drug that could provide the ever-elusive cure for diabetes.
Dr. Ben Pope is Co-founder and Chief Scientific Officer at MelliCell. Cross-trained in biology and engineering, Ben brings interdisciplinary expertise and management experience to lead our scientific and technology development efforts. Ben has been pursuing a cure for diabetes since his parents’ diagnosis over 20 years ago and is an inventor of MelliCell’s core technology.
832 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.